Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Braz. j. med. biol. res ; 33(12): 1491-6, Dec. 2000. graf
Artigo em Inglês | LILACS | ID: lil-274894

RESUMO

To assess the role of angiotensin II in the sensitivity of the baroreflex control of heart rate (HR) in normotensive rats (N = 6) and chronically hypertensive rats (1K1C, 2 months, N = 7), reflex changes of HR were evaluated before and after (15 min) the administration of a selective angiotensin II receptor antagonist (losartan, 10 mg/kg, iv). Baseline values of mean arterial pressure (MAP) were higher in hypertensive rats (195 ± 6 mmHg) than in normotensive rats (110 ± 2 mmHg). Losartan administration promoted a decrease in MAP only in hypertensive rats (16 percent), with no changes in HR. During the control period, the sensitivity of the bradycardic and tachycardic responses to acute MAP changes were depressed in hypertensive rats (~70 percent and ~65 percent, respectively) and remained unchanged after losartan administration. Plasma renin activity was similar in the two groups. The present study demonstrates that acute blockade of AT1 receptors with losartan lowers the MAP in chronic renal hypertensive rats without reversal of baroreflex hyposensitivity, suggesting that the impairment of baroreflex control of HR is not dependent on an increased angiotensin II level


Assuntos
Masculino , Animais , Ratos , Angiotensina II/fisiologia , Anti-Hipertensivos/uso terapêutico , Barorreflexo/efeitos dos fármacos , Frequência Cardíaca/efeitos dos fármacos , Hipertensão Renal/tratamento farmacológico , Losartan/uso terapêutico , Anti-Hipertensivos/farmacologia , Bradicardia/tratamento farmacológico , Doença Crônica , Frequência Cardíaca/efeitos dos fármacos , Losartan/farmacologia , Receptores de Angiotensina/antagonistas & inibidores , Receptores de Angiotensina/metabolismo , Taquicardia/tratamento farmacológico
2.
Braz. j. med. biol. res ; 32(3): 361-9, Mar. 1999.
Artigo em Inglês | LILACS | ID: lil-230466

RESUMO

Baroreflex sensitivity was studied in the same group of conscious rats using vasoactive drugs (phenylephrine and sodium nitroprusside) administered by three different approaches: 1) bolus injection, 2) steady-state (blood pressure (BP) changes produced in steps), 3) ramp infusion (30 s, brief infusion). The heart rate (HR) responses were evaluated by the mean index (mean ratio of all HR changes and mean arterial pressure (MAP) changes), by linear regression and by the logistic method (maximum gain of the sigmoid curve by a logistic function). The experiments were performed on three consecutive days. Basal MAP and resting HR were similar on all days of the study. Bradycardic responses evaluated by the mean index (-1.5 ñ 0.2, -2.1 ñ 0.2 and -1.6 ñ 0.2 bpm/mmHg) and linear regression (-1.8 ñ 0.3, -1.4 ñ 0.3 and -1.7 ñ 0.2 bpm/mmHg) were similar for all three approaches used to change blood pressure. The tachycardic responses to decreases of MAP were similar when evaluated by linear regression (-3.9 ñ 0.8, -2.1 ñ 0.7 and -3.8 ñ 0.4 bpm/mmHg). However, the tachycardic mean index (-3.1 ñ 0.4, -6.6 ñ 1 and -3.6 5 0.5 bpm/mmHg) was higher when assessed by the steady-state method. The average gain evaluated by logistic function (-3.5 ñ 0.6, -7.6 ñ 1.3 and -3.8 ñ 0.4 bpm/mmHg) was similar to the reflex tachycardic values, but different from the bradycardic values. Since different ways to change BP may alter the afferent baroreceptor function, the MAP changes obtained during short periods of time (up to 30 s: bolus and ramp infusion) are more appropriate to prevent the acute resetting. Assessment of the baroreflex sensitivity by mean index and linear regression permits a separate analysis of gain for reflex bradycardia and reflex tachycardia. Although two values of baroreflex sensitivity cannot be evaluated by a single symmetric logistic function, this method has the advantage of better comparing the baroreflex sensitivity of animals with different basal blood pressures


Assuntos
Animais , Masculino , Ratos , Barorreflexo , Determinação da Pressão Arterial/métodos , Pressão Sanguínea/fisiologia , Estado de Consciência , Frequência Cardíaca/fisiologia , Pressorreceptores/fisiologia , Análise de Variância , Pressão Sanguínea/efeitos dos fármacos , Bradicardia , Frequência Cardíaca/efeitos dos fármacos , Modelos Lineares , Nitroprussiato/farmacologia , Fenilefrina/farmacologia , Ratos Wistar , Taquicardia
3.
Braz. j. med. biol. res ; 23(11): 1185-93, 1990. ilus, tab
Artigo em Inglês | LILACS | ID: lil-91625

RESUMO

1. The effects of sodium pentabarbital and alfa-chloralose anesthesia on the barreflex control of ciruclation were studied in groups of 7 to 11 rats. The tests were performed in conscious undisturbed rats and repeated after anesthesia. 2. Pentobarbital (15 min) depressed the initial peak of the pressor response produced by carotid occlusion by 68% (15 ñ 1 vs 47 ñ 3 mmHg) and the mainteined rsponse by 52% (13 ñ 1 vs 27 ñ 4). Depression by chloralose was 48% (26 ñ 5 vs 50 ñ 3) and (19 ñ 2 vs 24 ñ 3), respectively. The inhibition progressively declined at 30, 60.90 and 120 min after pentobarbital but was unchanged up to 120 min after chloralose. 3. The baroreflex sensitivity index for bradycardic responses (phenylephrine injection) diminished by 50% after pentobarbital (-1.1 ñ 0.3 vs -2.2 ñ 0.3 beats/min per mmHg) and remained unaltered after chloralose. 4. The baroreflex sensitivity index for tachycardic responses (nitroprusside injection) was depressed by 61% after pentobarbital (-1.5 ñ 0.5 vs -3.8 - 0.5 beats/min per mmHg) and 35% after chloralose (-2.5 ñ 0.2 vs -3.9 ñ 0,5). 5. In general the depression of reflex control of ciruclation was more severe after pentobarbital than after chloralose anesthesia, while the resting control arterial pressurte was not affected by either. The inhibition of the baroreflex tachycardic responses was more intense than that of the bradycardic responses and represented a betther index of the depression exerted on the pressure responses to carotid occlusion


Assuntos
Ratos , Animais , Masculino , Cloralose/farmacologia , Frequência Cardíaca , Pentobarbital/administração & dosagem , Pressorreceptores/farmacologia , Bradicardia/induzido quimicamente , Cloralose/administração & dosagem , Nitroprussiato , Pentobarbital/administração & dosagem , Fenilefrina , Ratos Endogâmicos , Taquicardia/induzido quimicamente
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA